Published in Arthritis Rheum on May 15, 2008
Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest (2009) 1.56
Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol (2011) 1.38
Clinical characteristics of patients with anti-Jo-1 antibodies: a single center experience. J Clin Rheumatol (2009) 1.17
Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum (2009) 1.08
Clinical presentation and evaluation of dermatomyositis. Indian J Dermatol (2012) 1.08
Interstitial Lung Disease in Idiopathic Inflammatory Myopathy. Curr Rheumatol Rev (2010) 1.07
Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations. Arch Dermatol (2010) 1.05
Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients. Rheumatol Int (2009) 0.92
Clinical characteristics and outcomes of patients with idiopathic inflammatory myopathies from Jordan 1996-2009. Clin Rheumatol (2010) 0.88
The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum. Clin Exp Rheumatol (2012) 0.86
Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine. Arthritis Res Ther (2012) 0.86
Treatment with CA-074Me, a Cathepsin B inhibitor, reduces lung interstitial inflammation and fibrosis in a rat model of polymyositis. Lab Invest (2014) 0.82
Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.81
Acute Respiratory Distress Syndrome as the Initial Clinical Manifestation of an Antisynthetase Syndrome. Tuberc Respir Dis (Seoul) (2016) 0.79
Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease. Rheumatol Int (2015) 0.78
Polymyositis and dermatomyositis: Disease spectrum and classification. Indian J Dermatol (2012) 0.78
Developing better biomarkers for connective tissue disease-associated interstitial lung disease: citrullinated hsp90 autoantibodies in rheumatoid arthritis. Arthritis Rheum (2013) 0.76
[Dermatomyositis]. Z Rheumatol (2009) 0.75
Inflammatory lung disease a potential risk factor for onset of idiopathic inflammatory myopathies: results from a pilot study. RMD Open (2016) 0.75
Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study. Springerplus (2015) 0.75
Significance of myositis autoantibody in patients with idiopathic interstitial lung disease. Yonsei Med J (2015) 0.75
Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view. Korean J Intern Med (2017) 0.75
Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF). J Clin Med (2017) 0.75
119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord (2004) 2.85
Comparison of chest tomosynthesis and chest radiography for detection of pulmonary nodules: human observer study of clinical cases. Radiology (2008) 2.10
Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum (2005) 1.89
Low serum levels of vitamin D in idiopathic inflammatory myopathies. Ann Rheum Dis (2012) 1.59
Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies. J Clin Invest (2015) 1.51
Leukocytes, cytokines, growth factors and hormones in human skeletal muscle and blood after uphill or downhill running. J Physiol (2004) 1.49
Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol (2002) 1.35
A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies. Arthritis Rheum (2007) 1.31
Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study. Arthritis Res Ther (2009) 1.29
International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Rheum (2007) 1.28
Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus. Arthritis Rheum (2003) 1.20
Pathogenesis, classification and treatment of inflammatory myopathies. Nat Rev Rheumatol (2011) 1.18
Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis. Ann Neurol (2013) 1.16
T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells. J Immunol (2009) 1.15
Asthma treatment preference study: a conjoint analysis of preferred drug treatments. Chest (2004) 1.14
Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis Rheum (2013) 1.12
Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study. Arthritis Res Ther (2012) 1.11
Experiencing virtual patients in clinical learning: a phenomenological study. Adv Health Sci Educ Theory Pract (2011) 1.10
Pulmonary complications of polymyositis and dermatomyositis. Semin Respir Crit Care Med (2007) 1.10
Evaluation of sorafenib treatment in metastatic renal cell carcinoma with 2-fluoro-2-deoxyglucose positron emission tomography and computed tomography. Nucl Med Commun (2009) 1.10
Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease. Respir Med (2005) 1.09
Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis. Arthritis Rheum (2007) 1.08
Reliability and validity of the myositis disease activity assessment tool. Arthritis Rheum (2008) 1.07
Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol (2005) 1.07
Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Arthritis Rheum (2004) 1.06
Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis. Arthritis Rheum (2007) 1.04
Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies. FASEB J (2009) 1.04
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford) (2010) 1.04
Functional index-2: Validity and reliability of a disease-specific measure of impairment in patients with polymyositis and dermatomyositis. Arthritis Rheum (2006) 1.01
Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Medicine (Baltimore) (2012) 0.99
Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls. Curr Opin Rheumatol (2010) 0.97
Expanded T cell receptor Vβ-restricted T cells from patients with sporadic inclusion body myositis are proinflammatory and cytotoxic CD28null T cells. Arthritis Rheum (2010) 0.97
Upregulation of MHC class I in transgenic mice results in reduced force-generating capacity in slow-twitch muscle. Muscle Nerve (2009) 0.96
Exercise as an anti-inflammatory intervention to combat inflammatory diseases of muscle. Curr Opin Rheumatol (2009) 0.94
Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies. Curr Opin Rheumatol (2012) 0.94
Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis. Arthritis Rheum (2008) 0.94
Association of the proinflammatory haplotype (MICA5.1/TNF2/TNFa2/DRB1*03) with polymyositis and dermatomyositis. Arthritis Rheum (2004) 0.94
Endothelial cell activation and neovascularization are prominent in dermatomyositis. J Autoimmune Dis (2006) 0.93
Comparison of lung volume reduction surgery and physical training on health status and physiologic outcomes: a randomized controlled clinical trial. Chest (2005) 0.93
Lung density on high resolution computer tomography (HRCT) reflects degree of inflammation in smokers. Respir Res (2014) 0.93
A longitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis. Mol Med (2010) 0.93
Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy. Rheumatology (Oxford) (2013) 0.92
Impaired myofibrillar function in the soleus muscle of mice with collagen-induced arthritis. Arthritis Rheum (2009) 0.91
Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers. Rheumatology (Oxford) (2009) 0.91
Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction. J Rehabil Med (2003) 0.90
Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies. Arthritis Res Ther (2007) 0.90
Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD. Respir Med (2005) 0.89
Restricted T cell receptor BV gene usage in the lungs and muscles of patients with idiopathic inflammatory myopathies. Arthritis Rheum (2007) 0.89
Cell recovery in bronchoalveolar lavage fluid in smokers is dependent on cumulative smoking history. PLoS One (2012) 0.89
Bronchoalveolar lavage results are independent of season, age, gender and collection site. PLoS One (2012) 0.88
Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial. Arthritis Rheum (2007) 0.87
The role of TRAIL in mediating autophagy in myositis skeletal muscle: a potential nonimmune mechanism of muscle damage. Arthritis Rheum (2011) 0.87
Pathogenesis of idiopathic inflammatory myopathies. Curr Rheumatol Rep (2006) 0.87
TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis. Ann Rheum Dis (2012) 0.87
Cytokines in idiopathic inflammatory myopathies. Autoimmunity (2006) 0.87
Nodule detection in digital chest radiography: effect of anatomical noise. Radiat Prot Dosimetry (2005) 0.86
Tenascin-C and alpha-smooth muscle actin positive cells are increased in the large airways in patients with COPD. Respir Res (2011) 0.86
Serial analysis of Ro/SSA and La/SSB antibody levels and correlation with clinical disease activity in patients with systemic lupus erythematosus. Scand J Rheumatol (2002) 0.86
Pulmonary nodule size evaluation with chest tomosynthesis. Radiology (2012) 0.86
Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells. Arthritis Rheum (2009) 0.84
Patients with polymyositis or dermatomyositis have reduced grip force and health-related quality of life in comparison with reference values: an observational study. Rheumatology (Oxford) (2010) 0.84
Cardiovascular disease in patients with inflammatory rheumatic disease is associated with up-regulation of markers of inflammation in cardiac microvessels and cardiomyocytes. Arthritis Rheum (2010) 0.84
193rd ENMC International workshop Pathology diagnosis of idiopathic inflammatory myopathies 30 November - 2 December 2012, Naarden, The Netherlands. Neuromuscul Disord (2013) 0.84
Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies. Arthritis Rheum (2007) 0.84
New insights into the benefits of exercise for muscle health in patients with idiopathic inflammatory myositis. Curr Rheumatol Rep (2014) 0.84
Does individual learning styles influence the choice to use a web-based ECG learning programme in a blended learning setting? BMC Med Educ (2012) 0.84
Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up. Ann Rheum Dis (2013) 0.83
Polymyositis and dermatomyositis: pathophysiology. Rheum Dis Clin North Am (2011) 0.83
Genetically determined imbalance between serum levels of tumour necrosis factor (TNF) and interleukin (IL)-10 is associated with anti-Jo-1 and anti-Ro52 autoantibodies in patients with poly- and dermatomyositis. J Autoimmun (2006) 0.83
Occupational exposure and severe pulmonary fibrosis. Respir Med (2007) 0.83
Effect of radiation dose level on the detectability of pulmonary nodules in chest tomosynthesis. Eur Radiol (2014) 0.82
Expression of APRIL in diffuse large B cell lymphomas from patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol (2011) 0.82
Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies. Ann Rheum Dis (2007) 0.82
Improved exercise performance and increased aerobic capacity after endurance training of patients with stable polymyositis and dermatomyositis. Arthritis Res Ther (2013) 0.81
Detection of Chlamydia pneumoniae on cytospin preparations from bronchoalveolar lavage in COPD patients and in lung tissue from advanced emphysema. Int J Chron Obstruct Pulmon Dis (2007) 0.81
Learning aspects and potential pitfalls regarding detection of pulmonary nodules in chest tomosynthesis and proposed related quality criteria. Acta Radiol (2011) 0.81
Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies. Autoimmun Rev (2009) 0.81
Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis. Ann Rheum Dis (2012) 0.81
Vascular involvement in the pathogenesis of idiopathic inflammatory myopathies. Autoimmunity (2009) 0.81
Interrater reliability and aspects of validity of the myositis damage index. Ann Rheum Dis (2011) 0.81
Development of the myositis activities profile--validity and reliability of a self-administered questionnaire to assess activity limitations in patients with polymyositis/dermatomyositis. J Rheumatol (2002) 0.81
Effects of smoking, gender and occupational exposure on the risk of severe pulmonary fibrosis: a population-based case-control study. BMJ Open (2014) 0.81
Evaluation of an improved method of simulating lung nodules in chest tomosynthesis. Acta Radiol (2012) 0.81
Progressive multifocal leukoencephalopathy in a patient with polymyositis: case report and literature review. J Rheumatol (2012) 0.80
Autoantibodies produced at the site of tissue damage provide evidence of humoral autoimmunity in inclusion body myositis. PLoS One (2012) 0.80
Proteomic profiling reveals autoimmune targets in sarcoidosis. Am J Respir Crit Care Med (2015) 0.80
Higher pain sensitivity and lower muscle strength in postmenonpausal women with early rheumatoid arthritis compared with age-matched healthy women--a pilot study. Disabil Rehabil (2013) 0.78
Patient-reported outcomes and adult patients' disease experience in the idiopathic inflammatory myopathies. report from the OMERACT 11 Myositis Special Interest Group. J Rheumatol (2014) 0.78
Elevated expression of prostaglandin E2 synthetic pathway in skeletal muscle of prior polio patients. J Rehabil Med (2014) 0.78
Idiopathic inflammatory myopathies - myositis. Best Pract Res Clin Rheumatol (2002) 0.78
Large organic aerosols in a dynamic and continuous whole-body exposure chamber tested on humans and on a heated mannequin. Ann Occup Hyg (2006) 0.77
Clinical symptoms in patients with myositis-an acquired metabolic myopathy? Curr Opin Rheumatol (2003) 0.77